Gabriela Hobbs, MD
Massachusetts General Hospital · Harvard Medical School Massachussets General Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gabriela Hobbs, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:48 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07104799 · Momelotinib During and After HCT in MyelofibrosisMassachusetts General Hospital · recruiting · Myelofibrosis, Hematopoietic Cell Transplantation (HCT) · principal investigator
- N/ANCT05842603 · I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm PatientsMassachusetts General Hospital · recruiting · Myeloproliferative Disorders, Leukemia · principal investigator
- Ph2NCT04644211 · Ruxolitinib in Thrombocythemia and Polycythemia VeraMassachusetts General Hospital · recruiting · Essential Thrombocythemia, Polycythemia Vera · principal investigator
- Ph2NCT03427866 · Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.Massachusetts General Hospital · completed · Myelofibrosis · principal investigator
- Ph2NCT03065400 · PD-1 Inhibition in Advanced Myeloproliferative NeoplasmsJohn Mascarenhas · completed · Chronic Phase Myelofibrosis, Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis · study chair
- Ph1NCT03042689 · Study of Regorafenib in Patients With Advanced Myeloid MalignanciesMassachusetts General Hospital · completed · Acute Myeloid Leukemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.